Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209–49.

PubMed  Google Scholar 

Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, Jin L, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70:674–83.

Article  PubMed  Google Scholar 

McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19:223–38.

Article  PubMed  PubMed Central  Google Scholar 

Valery PC, Laversanne M, Clark PJ, Petrick JL, McGlynn KA, Bray F. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology (Baltimore, MD). 2018;67:600–11.

Article  PubMed  Google Scholar 

Choi S, Kim BK, Yon DK, Lee SW, Lee HG, Chang HH, Park S, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the global burden of disease 2019 study. Clin Mol Hepatol. 2023;29:433–52.

Article  PubMed  PubMed Central  Google Scholar 

Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598–606.

Article  PubMed  PubMed Central  Google Scholar 

Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589–604.

Article  PubMed  PubMed Central  Google Scholar 

Yang JD, Gyedu A, Afihene MY, Duduyemi BM, Micah E, Kingham TP, Nyirenda M, et al. Hepatocellular carcinoma occurs at an earlier age in Africans, particularly in association with chronic hepatitis B. Am J Gastroenterol. 2015;110:1629–31.

Article  CAS  PubMed  Google Scholar 

Yang JD, Mohamed EA, Aziz AOA, Shousha HI, Hashem MB, Nabeel MM, Abdelmaksoud AH, et al. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa liver cancer consortium. Lancet Gastroenterol Hepatol. 2017;2:103–11.

Article  PubMed  Google Scholar 

World Health Organization. Global status report on alcohol and health and treatment of substance use disorders 2018. WHO https://www.who.int/publications/i/item/9789240096745 (2024).

Guo W, Ge X, Lu J, Xu X, Gao J, Wang Q, Song C, et al. Diet and risk of non-alcoholic fatty liver disease, cirrhosis, and liver cancer: a large prospective cohort study in UK biobank. Nutrients. 2022;14:5335.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. (2020). World cancer report: cancer research for cancer prevention. https://www.iarc.who.int/featured-news/new-world-cancer-report/.

World Health Organization-International Agency for Research on Cancer. World cancer report. https://www.iarc.who.int/cards_page/world-cancer-report/.

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England) 2024;403:2133–2161.

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet (London, England) 2024;403:2162–2203.

Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2010;2022:34.

Google Scholar 

Hsu Y-C, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20:524–37.

Article  PubMed  Google Scholar 

Martinello M, Solomon SS, Terrault NA, Dore GJ. Hepatitis C. Lancet (London, England). 2023;402:1085–96.

Article  PubMed  Google Scholar 

WHO Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. World Health Organization, Geneva2022.

Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, Islami F, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021;22:1071–80.

Article  PubMed  PubMed Central  Google Scholar 

Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the global burden of disease study 2020. Lancet (London, England) 2022;400: 185–235

Pan W-C, Wu C-D, Chen M-J, Huang Y-T, Chen C-J, Su H-J, Yang H-I. Fine particle pollution, alanine transaminase, and liver cancer: a Taiwanese prospective cohort study (REVEAL-HBV). J National Cancer Instit. 2016;108:djv341.

Article  Google Scholar 

Kivimäki M, Batty GD, Pentti J, Shipley MJ, Sipilä PN, Nyberg ST, Suominen SB, et al. Association between socioeconomic status and the development of mental and physical health conditions in adulthood: a multi-cohort study. The Lancet Public Health. 2020;5:e140–9.

Article  PubMed  Google Scholar 

Tan X, Chapman CD, Cedernaes J, Benedict C. Association between long sleep duration and increased risk of obesity and type 2 diabetes: a review of possible mechanisms. Sleep Med Rev. 2018;40:127–34.

Article  PubMed  Google Scholar 

Wang Y-H, Li J-Q, Shi J-F, Que J-Y, Liu J-J, Lappin JM, Leung J, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020;25:1487–99.

Article  PubMed  Google Scholar 

Sohn W, Lee HW, Lee S, Lim JH, Lee MW, Park CH, Yoon SK. Obesity and the risk of primary liver cancer: a systematic review and meta-analysis. Clin Mol Hepatol. 2021;27:157–74.

Article  PubMed  Google Scholar 

Kew MC. Aflatoxins as a cause of hepatocellular carcinoma. J Gastrointestinal Liver Diseases : JGLD. 2013;22:305–10.

Google Scholar 

Ueno Y, Nagata S, Tsutsumi T, Hasegawa A, Watanabe MF, Park HD, Chen GC, et al. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis. 1996;17:1317–21.

Article  CAS  PubMed  Google Scholar 

Alcorn T. Mongolia’s struggle with liver cancer. Lancet (London, England). 2011;377:1139–40.

Article  PubMed  Google Scholar 

Dondog B, Lise M, Dondov O, Baldandorj B, Franceschi S. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia. Euro J Cancer Prev: Off J Euro Cancer Prev Org (ECP). 2011;20:33–9.

Article  CAS  Google Scholar 

WHO Regional Office for the Western Pacific. Viral hepatitis in Mongolia: situation and response. Manila: World Health Organization Regional Office for the Western Pacific; 2015.

Google Scholar 

Yang W-S, Zeng X-F, Liu Z-N, Zhao Q-H, Tan Y-T, Gao J, Li H-L, et al. Diet and liver cancer risk: a narrative review of epidemiological evidence. Br J Nutr. 2020;124:330–40.

Article  CAS  PubMed  Google Scholar 

Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20:37–49.

Article  PubMed  Google Scholar 

Barouki R, Samson M, Blanc EB, Colombo M, Zucman-Rossi J, Lazaridis KN, Miller GW, et al. The exposome and liver disease - how environmental factors affect liver health. J Hepatol. 2023;79:492–505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim D-S, Scherer PE. Obesity, diabetes, and increased cancer progression. Diabetes Metab J. 2021;45:799–812.

Article  PubMed  PubMed Central  Google Scholar 

Rajesh Y, Sarkar D. Association of adipose tissue and adipokines with development of obesity-induced liver cancer. Int J Mol Sci. 2021;22:2163.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang J, He J, Feng Y, Xiang M. Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling. Front Immunol. 2023;14:1166440.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (London, England). 2020;40:205–10.

Article  Google Scholar 

Chu Y-J, Yang H-I, Wu H-C, Lee M-H, Liu J, Wang L-Y, Lu S-N, et al. Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. Euro J Cancer (Oxford, England: 1990). 2018;94:37–46.

Article  CAS  Google Scholar